Stocks
GlaxoSmithKline (GSK) Net profit US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net profit, £ | ? | 4 921 000 000 | 14 956 000 000 | 4 921 000 000 | 4 928 000 000 | 4 928 000 000 | 2 103 000 000 | ||
| Changes by years, y/y, % | +12% | +204% | -67% | +0% | 0% | +6.3% | |||
GlaxoSmithKline. Net profit US GAAP, £
GlaxoSmithKline. Net profit US GAAP, changes, %
GlaxoSmithKline. Net profit US GAAP, sum by quarters, £
GlaxoSmithKline (GSK) Net profit US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net profit, £ | ? | 1 173 000 000 | 1 046 000 000 | -58 000 000 | 1 173 000 000 | -58 000 000 | 2 103 000 000 | |
| Changes by years, y/y, % | -28% | -30% | -104% | -28% | -104% | |||
| Changes by quarters, q/q, % | +235% | -11% | -106% | -2 122% | -105% | |||
